M. J. During

1.3k total citations
16 papers, 1.1k citations indexed

About

M. J. During is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, M. J. During has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Psychiatry and Mental health. Recurrent topics in M. J. During's work include Epilepsy research and treatment (5 papers), Neuroscience and Neuropharmacology Research (3 papers) and Virus-based gene therapy research (2 papers). M. J. During is often cited by papers focused on Epilepsy research and treatment (5 papers), Neuroscience and Neuropharmacology Research (3 papers) and Virus-based gene therapy research (2 papers). M. J. During collaborates with scholars based in United States and New Zealand. M. J. During's co-authors include Dennis D. Spencer, R. S. Sherwin, Michael Brines, M A Borg, Walter P. Borg, Gerald I. Shulman, Paola Leone, Robert H. Roth, Andrew Freese and Joyce A. Cramer and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Clinical Endocrinology & Metabolism and Neurology.

In The Last Decade

M. J. During

16 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. J. During United States 12 435 311 235 203 177 16 1.1k
Sara Xapelli Portugal 26 786 1.8× 606 1.9× 120 0.5× 95 0.5× 117 0.7× 57 1.8k
S.M.O. Hourani United Kingdom 25 300 0.7× 592 1.9× 206 0.9× 1.4k 6.8× 336 1.9× 59 1.8k
David P. Westfall United States 25 684 1.6× 984 3.2× 133 0.6× 779 3.8× 361 2.0× 71 2.2k
Mila Vlaskovska Bulgaria 16 404 0.9× 364 1.2× 53 0.2× 159 0.8× 252 1.4× 44 1.2k
Joan A. Sim United Kingdom 18 325 0.7× 372 1.2× 108 0.5× 573 2.8× 290 1.6× 21 1.5k
Hilary Lloyd Australia 16 550 1.3× 349 1.1× 69 0.3× 307 1.5× 157 0.9× 29 1.0k
E. Ongini Italy 26 784 1.8× 882 2.8× 126 0.5× 805 4.0× 134 0.8× 91 2.1k
Alexander Kharlamov United States 18 316 0.7× 308 1.0× 106 0.5× 52 0.3× 272 1.5× 46 1.2k
Adriaan den Hertog Netherlands 20 430 1.0× 610 2.0× 34 0.1× 289 1.4× 83 0.5× 53 1.1k
Edward C. Burgard United States 21 925 2.1× 684 2.2× 168 0.7× 668 3.3× 360 2.0× 39 1.9k

Countries citing papers authored by M. J. During

Since Specialization
Citations

This map shows the geographic impact of M. J. During's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. J. During with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. J. During more than expected).

Fields of papers citing papers by M. J. During

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. J. During. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. J. During. The network helps show where M. J. During may publish in the future.

Co-authorship network of co-authors of M. J. During

This figure shows the co-authorship network connecting the top 25 collaborators of M. J. During. A scholar is included among the top collaborators of M. J. During based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. J. During. M. J. During is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Metzger, Gregory A., et al.. (2014). Gene-directed enzyme prodrug therapy for localized chemotherapeutics in allograft and xenograft tumor models. Cancer Gene Therapy. 21(10). 434–440. 8 indexed citations
2.
Janson, Christopher G., Scott McPhee, Paola Leone, Andrew Freese, & M. J. During. (2001). Viral-based gene transfer to the mammalian CNS for functional genomic studies. Trends in Neurosciences. 24(12). 706–712. 38 indexed citations
3.
Leone, Paola, et al.. (1999). Global CNS gene transfer for a childhood neurogenetic enzyme deficiency: Canavan disease.. PubMed. 1(4). 487–92. 35 indexed citations
4.
Mattson, Richard H., et al.. (1998). Novel methods for studying new antiepileptic drug pharmacology.. PubMed. 76. 105–12. 4 indexed citations
5.
Freese, Andrew, M. J. During, Beverly L. Davidson, et al.. (1996). Transfection of human lactotroph adenoma cells with an adenovirus vector expressing tyrosine hydroxylase decreases prolactin release.. The Journal of Clinical Endocrinology & Metabolism. 81(6). 2401–2404. 18 indexed citations
6.
Maggs, David, Ralph Jacob, Frances Rife, et al.. (1995). Interstitial fluid concentrations of glycerol, glucose, and amino acids in human quadricep muscle and adipose tissue. Evidence for significant lipolysis in skeletal muscle.. Journal of Clinical Investigation. 96(1). 370–377. 136 indexed citations
7.
Borg, Walter P., M. J. During, R. S. Sherwin, et al.. (1994). Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia.. Journal of Clinical Investigation. 93(4). 1677–1682. 220 indexed citations
8.
Scheyer, Richard D., et al.. (1994). Phenytoin concentrations in the human brain: An in vivo microdialysis study. Epilepsy Research. 18(3). 227–232. 45 indexed citations
9.
Scheyer, Richard D., M. J. During, Dennis D. Spencer, Joyce A. Cramer, & R. H. Mattson. (1994). Measurement of carbamazepine and carbamazepine epoxide in the human brain using in vivo microdialysis. Neurology. 44(8). 1469–1469. 38 indexed citations
10.
Scheyer, Richard D., et al.. (1994). Simultaneous HPLC Analysis of Carbamazepine and Carbamazepine Epoxide in Human Brain Microdialysate. Journal of Liquid Chromatography. 17(7). 1567–1576. 10 indexed citations
11.
Young, Richard S., et al.. (1993). Effect of anoxia on excitatory amino acids in brain slices of rats and turtles: in vitro microdialysis. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 264(4). R716–R719. 19 indexed citations
12.
During, M. J., Andrew Freese, Ariel Y. Deutch, et al.. (1992). Biochemical and behavioral recovery in a rodent model of Parkinson's disease following stereotactic implantation of dopamine-containing liposomes. Experimental Neurology. 115(2). 193–199. 50 indexed citations
13.
During, M. J., et al.. (1992). Effect of amygdala kindling on the in vivo release of GABA and 5-HT in the dorsal raphe nucleus in freely moving rats. Brain Research. 584(1-2). 36–44. 25 indexed citations
14.
During, M. J. & Dennis D. Spencer. (1992). Adenosine: A potential mediator of seizure arrest and postictal refractoriness. Annals of Neurology. 32(5). 618–624. 401 indexed citations
15.
Freese, Andrew, et al.. (1991). Expression of tyrosine hydroxylase in striatal cells with a hsv 1 vector causes stable production of regulated release of dopa and dopamine potential gene therapy for parkinsons disease. The Society for Neuroscience Abstracts. 17. 1077. 1 indexed citations
16.
Bean, Andrew J., M. J. During, & Robert H. Roth. (1990). Effects of dopamine autoreceptor stimulation on the release of colocalized transmitters: In vivo release of dopamine and neurotensin from rat prefrontal cortex. Neuroscience Letters. 108(1-2). 143–148. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026